Dr. Sigal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10710 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-5269Fax+1 858-554-8946
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of California Davis HealthResidency, Internal Medicine, 2002 - 2005
- David Geffen School of Medicine at UCLAClass of 2002
Certifications & Licensure
- CA State Medical License 2003 - 2025
- IL State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia Start of enrollment: 2009 Jan 01
- Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Start of enrollment: 2011 Nov 01
- TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma Start of enrollment: 2014 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 309 citationsHALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Duct...Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock, Tara Elisabeth Seery, William P. Harris
Journal of Clinical Oncology. 2017-12-12 - 136 citationsRandomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerMitesh J. Borad, Shantan G. Reddy, Nathan Bahary, Hope E. Uronis, Darren Sigal
Journal of Clinical Oncology. 2015-05-01 - 908 citationsEntrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trialsRobert C. Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T. Shaw
The Lancet. Oncology. 2020-02-01
Press Mentions
- Abivax's Phase 1/2 Clinical Study Results of ABX196 in Liver Cancer to Be Presented on Jan. 21, at ASCO GI Cancers Symposium 2022January 18th, 2022
- Magazine Covers New Liver Cancer Clinical Trial at Scripps MD AndersonDecember 20th, 2019
- Novel Liver Cancer Clinical Trial to Begin at Scripps MD Anderson Cancer CenterJuly 19th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: